Molecular and Cellular Biochemistry

, Volume 279, Issue 1–2, pp 97–104 | Cite as

Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium

  • Alexandra C. MillerEmail author
  • Catherine Bonait-Pellie
  • Robert F. Merlot
  • John Michel
  • Michael Stewart
  • Paul D. Lison


Depleted uranium (DU) is a dense heavy metal used in military applications. During military conflicts, US military personnel have been wounded by DU shrapnel. The health effects of embedded DU are unknown. Published data from our laboratory demonstrated that DU exposure in vitro can transform immortalized human osteoblast cells (HOS) to the tumorigenic phenotype. Results from our laboratory have also shown that DU is genotoxic and mutagenic in cultured human cells. Internalized DU could be a carcinogenic risk and concurrent alpha particle and heavy metal toxic effects complicate this potential risk. Anecdotal reports have suggested that DU can cause leukemia. To better assess this risk, we have developed an in vivo leukemogenesis model. This model involves using murine hematopoietic cells (FDC-P1) that are dependent on stimulation by granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin 3 (IL-3) and injected into mice to produce myeloid leukemia. Although immortalized, these cells are not tumorigenic on subcutaneous inoculation in mice. Intravenous injection of FDC-P1 cells into DU-implanted DBA/2 mice was followed by the development of leukemias in 76% of all mice implanted with DU pellets. In contrast, only 12% of control mice developed leukemia. Karyotypic analysis confirmed that the leukemias originated from FDC-P1 cells. The growth properties of leukemic cells from bone marrow, spleen, and lymph node were assessed and indicate that the FDC-P1 cells had become transformed in vivo. The kidney, spleen, bone marrow, muscle, and urine showed significant elevations in tissue uranium levels prior to induction of leukemia. These results demonstrated that a DU altered in vivo environment may be involved in the pathogenesis of DU induced leukemia in an animal model.

Key Words

DBA depleted uranium heavy-metals internal exposure leukemia mice 



depleted uranium


factor-dependent cells


interleukin 3


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller AC, Blakely WF, Livengood D, Whittaker T, Xu J, Ejnik JW, Hamilton MM, Parlette E, St. John T, Gerstenberg HM, Hsu H: Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride. Environ Health Perspect 106: 465–471, 1998PubMedGoogle Scholar
  2. 2.
    Miller AC, Fuciarelli AF, Jackson WE, Ejnik EJ, Emond C, Strocko S, Hogan J, Page N, Pellmar T: Urinary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets. Mutagenesis 13: 101–106, 1998Google Scholar
  3. 3.
    Andrew SP, Caligiuri RD, Eiselstein LE: A review of penetration mechanisms and dynamic properties of tungsten and depleted uranium penetrators. In: A. Crowson, E.S. Chen (eds). Tungsten and Tungsten Alloys: Recent Advances, Plenum Press, NY, 1991Google Scholar
  4. 4.
    Miller AC, Whittaker T, Hogan J, McBride S, Benson K: Oncogenes as biomarkers for low dose radiation-induced health effects. Can Detect Prev 20: 235–236, 1996Google Scholar
  5. 5.
    Pellmar TC, Fuciarelli AF, Ejnik JW, Hamilton M, Hogan J, Strocko S, Emond C, Mottaz HM, Landauer MR: Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol Sci 49: 29–39, 1999CrossRefPubMedGoogle Scholar
  6. 6.
    Pellmar TC, Kaiser DO, Emond C, Hogan JB: Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments. Neurotoxicology 20: 785–792, 1999PubMedGoogle Scholar
  7. 7.
    Miller AC, Xu J, Mog S, McKinney L, Page N: Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: Induction of genotoxic effects. Carcinogenesis 22: 115–125, 2001CrossRefPubMedGoogle Scholar
  8. 8.
    Miller AC, Brooks K, Stewart M, Shi L, McClain D, Page N: Genomic instability in human osteoblast cells after exposure to depleted uranium: Delayed lethality and micronucleus formation. J Environ Radioact 64: 247–259, 2003CrossRefPubMedGoogle Scholar
  9. 9.
    Miller AC, Xu J, Stewart M, Brooks K, Hodge S, Shi L, Page N, McClain D: Observation of radiation specific damage in human cells exposed to depleted uranium: Dicentric frequency and neoplastic transformation as endpoints. Radiat Protect Dosim 99: 275–278, 2002Google Scholar
  10. 10.
    Miller AC, Brooks K, Smith J, Page N: Effect of militarily relevant heavy metals, depleted uranium and heavy metal tungsten alloy on gene expression in human liver carcinoma cells [HePG2]. Molec Cell Biochem 255: 247–256, 2004vadjustGoogle Scholar
  11. 11.
    Mould RF: Depleted uranium and radiation-induced lung cancer and leukemia. Br Radiol 74: 677–683, 2001Google Scholar
  12. 12.
    Duhrsen D, Metcalf D: A model system for leukemic transformation of immortalized hemopoietic cells in irradiated recipient mice. Leukemia 2: 329–333, 1988PubMedGoogle Scholar
  13. 13.
    Duhrsen D, Metcalf D: Factors influencing the time and site of leukemic transformation of factor-dependent cells after injection into irradiated recipient mice. Int J Can 44: 1074–1081, 1989Google Scholar
  14. 14.
    Duhrsen D, Metcalf D. Effects of irradiation of recipient mice on the behavior and leukemogenic potential of factor-dependent hematopoietic cell lines. Blood 75: 190–197, 1990Google Scholar
  15. 15.
    Blumenstein M, Hossfield DK, Duhrsen U: Indirect radiation leukemogenesis in DBA/2 mice: Increased expression of B2 repeats in FDC-P1 cells transformed by intracisternal A-particle transposition. Ann Hematol 76: 53–60, 1998CrossRefPubMedGoogle Scholar
  16. 16.
    Ejnik JW, Carmichael AJ, Hamilton MM, McDiarmid M, Squibb K, Boyd P, Tardiff W: Determination of the isotopic composition of uranium in urine by inductively coupled plasma mass spectrometry. Health Phys 78: 143–146, 2000CrossRefPubMedGoogle Scholar
  17. 17.
    Danesi PR, Bleise A, Burkart W, Cabianca T, Campbell MJ, Makarewicz M, Moreno J, Tuniz C, Hotchkis M: Isotopic composition and origin of uranium and plutonium in selected soil samples collected in Kosovo. J Environ Radioact 64: 121–131, 2003PubMedGoogle Scholar
  18. 18.
    National Research Council Committee on Biological Effects of Ionizing Radiation: Health Effects of Exposure to Radon – BEIR VI, National Academy Press, Washington, DC, 1999Google Scholar
  19. 19.
    Ellender M. Harrison JD, Pottinger H, Thomas JM: Induction of osteosarcoma and acute myeloid leukaemia in CBA/H mice by the alpha-emitting nuclides, uranium-233, plutonium-239, and amercium-241. Int J Radiat Biol 77: 41–52, 2001CrossRefPubMedGoogle Scholar
  20. 20.
    Harrison JD, Muirhead CR, Harrison: Quantitative comparisons of cancer induction in humans by internally deposited radionuclides and external radiation. Int J Radiat Biol 79: 1–13, 2003PubMedGoogle Scholar
  21. 21.
    Waalkes MP, Rehm S, Sass B, Ward JM: Induction of tumors of the hematopoietic system by cadmium in rats. IARC Sci Pub 118: 401–404, 1992Google Scholar
  22. 22.
    Costa M: Molecular mechanisms of nickel carcinogenesis. J Biol Chem 383: 961–967, 2002CrossRefGoogle Scholar
  23. 23.
    Shi X: Molecular mechanisms of Cr[VI]-induced carcinogenesis. Mol Cell Biochem 234: 293–300, 2002CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Alexandra C. Miller
    • 1
    • 3
    Email author
  • Catherine Bonait-Pellie
    • 2
  • Robert F. Merlot
    • 2
  • John Michel
    • 2
  • Michael Stewart
    • 1
  • Paul D. Lison
    • 2
  1. 1.Applied Cellular Radiobiology DepartmentArmed Forces Radiobiology Research, InstituteBethesdaUSA
  2. 2.Department of Occupational and Environmental MedicineUniversity of ParisParisFrance
  3. 3.Applied Cellular Radiobiology DepartmentAFRRIBethesdaUSA

Personalised recommendations